- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pacific Edge Ltd (PEB)
Pacific Edge Ltd stock price live, this page displays NZ PEB stock exchange data. View the PEB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pacific Edge Ltd real time stock price chart below.
What Is the Pacific Edge Ltd Stock Price Today?
The Pacific Edge Ltd stock price today is 0.3050.
What Is the Stock Symbol for Pacific Edge Ltd?
The stock symbol for Pacific Edge Ltd is "PEB."
What Stock Exchange Does Pacific Edge Ltd Trade On?
Pacific Edge Ltd is listed and trades on the New Zealand stock exchange.
Is Pacific Edge Ltd a Good Stock to Buy?
Determining whether Pacific Edge Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PEB quote. (ISIN: NZPEBE0002S1)
What Is the Pacific Edge Ltd Stock Price Today?
The Pacific Edge Ltd stock price today is 0.3050.
What Is the Stock Symbol for Pacific Edge Ltd?
The stock symbol for Pacific Edge Ltd is "PEB."
What Stock Exchange Does Pacific Edge Ltd Trade On?
Pacific Edge Ltd is listed and trades on the New Zealand stock exchange.
Is Pacific Edge Ltd a Good Stock to Buy?
Determining whether Pacific Edge Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PEB quote. (ISIN: NZPEBE0002S1)
0.3050
-0.0050(-1.61%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3000
0.3100
52 wk Range
0.0950
0.3400
PEB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.30000.3100
52 wk Range
0.09500.3400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PEB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
0.2000
Downside
-34.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.2000
(-34.43% Downside)
Pacific Edge Ltd Earnings Call Summary for H2/2026
- Revenue plunged 47.4% YoY to NZD 11.5M due to Medicare non-coverage; net loss reached NZD 35.8M despite 9.5% expense reduction.
- Completed NZD 25.4M capital raise with strong shareholder support; cash burn improved to NZD 2.4M monthly in H2 FY2026.
- Stock rose 5.56% to $0.285 on optimism around next-generation tests showing superior clinical performance characteristics.
- Building infrastructure for increased test volumes ahead of full commercial launch; targeting APAC profitability and U.S. market expansion.
- Medicare re-coverage timeline and transition from legacy products remain key risks; analysts question path to profitability amid ongoing losses.
Last Updated: 05/25/2026, 08:10 AM
Read Full TranscriptEarnings
Latest Release
May 24, 2026
EPS / Forecast
-0.02 / --
Revenue / Forecast
6.18M / --
Compare PEB to Peers and Sector
Metrics to compare | PEB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPEBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.0x | −1.7x | −0.5x | |
PEG Ratio | 3.63 | −0.06 | 0.00 | |
Price/Book | 33.5x | 2.6x | 2.6x | |
Price / LTM Sales | 27.5x | 13.1x | 3.0x | |
Upside (Analyst Target) | −34.4% | 105.0% | 58.6% | |
Fair Value Upside | Unlock | 12.0% | 10.2% | Unlock |
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the stratification and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up in microhematuria patients; Cxbladder Detect, which improve practice workflow and efficiency in urological care; Cxbladder Triage Plus, a non-invasive surveillance alternative that can reduce the burden of repeated cystoscopy in patients; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a recurrent non-muscle invasive bladder cancer. In addition, the company is developing products for bladder, gastric, colorectal and endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pacific Edge (PEB) Stock Price Today?
The Pacific Edge stock price today is 0.3050 NZD.
What Stock Exchange Does Pacific Edge Trade On?
Pacific Edge is listed and trades on the New Zealand Exchange.
What Is the Stock Symbol for Pacific Edge?
The stock symbol for Pacific Edge is "PEB."
What Is the Pacific Edge Market Cap?
As of today, Pacific Edge market cap is 357.4600M NZD.
What Is Pacific Edge's Earnings Per Share (TTM)?
The Pacific Edge EPS (TTM) is -0.0379.
When Is the Next Pacific Edge Earnings Date?
Pacific Edge will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is PEB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pacific Edge Stock Split?
Pacific Edge has split 5 times.
How Many Employees Does Pacific Edge Have?
Pacific Edge has 114 employees.
What is the current trading status of Pacific Edge (PEB)?
As of Jun 17, 2026, Pacific Edge (PEB) is trading at a price of 0.3050 NZD, with a previous close of 0.3050 NZD. The stock has fluctuated within a day range of 0.3000 NZD to 0.3100 NZD, while its 52-week range spans from 0.0950 NZD to 0.3400 NZD.
What Is Pacific Edge (PEB) Price Target According to Analysts?
The average 12-month price target for Pacific Edge is 0.2000 NZD, with a high estimate of 0.2 NZD and a low estimate of 0.2 NZD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -34.43% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.